Evidence map›Paper›PMID 26391765›Full record

ArticleScientific reports2015

RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules.

Yang Li, Mahlon Collins, Rachel Geiser, Nadine Bakkar, David Riascos, Robert Bowser

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 51 citations in OpenAlex.

  1. RBM45 Preferential Binding to mThe journal of physical chemistry. B · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. RBM45 is an mCell reports · 2022
    Article
  6. Article
  7. Autophagy of the mNature communications · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yang LiDivisions of Neurology and Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
Mahlon CollinsDivisions of Neurology and Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
Rachel GeiserDivisions of Neurology and Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
Nadine BakkarDivisions of Neurology and Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
David RiascosDivisions of Neurology and Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
Robert BowserDivisions of Neurology and Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
St. Joseph's Hospital and Medical Center · USBarrow Neurological Institute · US

Funding

Peptide and Protein Biomarkers for Amyotrophic Lateral Sclerosis (ALS)R01NS061867 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOWSER, ROBERT P · 2009 to 2013
$1.6M
Multi-Center Validation of Biomarkers for Motor Neuron DiseaseRC1NS068179 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOWSER, ROBERT P, CUDKOWICZ, MERIT E · 2009 to 2010
$977k
Peptide and Protein Biomarkers for Amyotrophic Lateral Sclerosis (ALS)R56NS061867 · NINDS · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI BOWSER, ROBERT P · 2014 to 2014
$687k
The Functional Role of RBM45 in Gene Expression and NeurodegenerationF31NS080614 · NINDS · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI COLLINS, MAHLON · 2012 to 2014
$119k
NINDS NIH HHS F31 NS080614NINDS NIH HHS NS061867NINDS NIH HHS NS068179NINDS NIH HHS R01 NS061867NINDS NIH HHS R56 NS061867NINDS NIH HHS RC1 NS068179
6 · The paper itself

Abstract

The aggregation of RNA-binding proteins is a pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). RBM45 is an RNA-binding protein that forms cytoplasmic inclusions in neurons and glia in ALS and FTLD. To explore the role of RBM45 in ALS and FTLD, we examined the contribution of the protein's domains to its function, subcellular localization, and interaction with itself and ALS-linked proteins. We find that RBM45 forms homo-oligomers and physically associates with the ALS-linked proteins TDP-43 and FUS in the nucleus. Nuclear localization of RBM45 is mediated by a bipartite nuclear-localization sequence (NLS) located at the C-terminus. RBM45 mutants that lack a functional NLS accumulate in the cytoplasm and form TDP-43 positive stress granules. Moreover, we identify a novel structural element, termed the homo-oligomer assembly (HOA) domain, that is highly conserved across species and promote homo-oligomerization of RBM45. RBM45 mutants that fail to form homo-oligomers exhibit significantly reduced association with ALS-linked proteins and inclusion into stress granules. These results show that RMB45 may function as a homo-oligomer and that its oligomerization contributes to ALS/FTLD RNA-binding protein aggregation.

Indexed as

Protein MultimerizationActive Transport, Cell NucleusAmino Acid SequenceCarrier ProteinsCell LineDNA-Binding ProteinsHumansInclusion BodiesMolecular Sequence DataMutationNerve Tissue ProteinsNuclear Localization SignalsProtein Aggregation, PathologicalProtein BindingProtein Interaction Domains and MotifsProtein Interaction MapsCarrier ProteinsDNA-Binding ProteinsNerve Tissue ProteinsNuclear Localization SignalsRBM45 protein, humanRNA-Binding Protein FUSRNA-Binding Proteins

Identifiers

PMID26391765
PMCPMC4585734
OpenAlexW2410818682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.